FDA
-
-
-
-
-
-
-
Sonoma Pharmaceuticals (SNOA) Expanded Indication for Alevicyn Approved by FDA
-
-
-
-
-
-
-
Sonoma Pharmaceuticals Reports Financial Results for Fourth Quarter and Fiscal Year 2017
-
-
-
330,120 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

